Detection of GAD65-reactive T-cells in type 1 diabetes by immunoglobulin-free ELISPOT assays

Diabetes Care

Volumn 25, Issue 8, 2002, Pages 1390-1397

  Kotani, Reiko ^a   Nagata, Masao ^a   Moriyama, Hiroaki ^a   Nakayama, Maki ^a   Yamada, Katsumi ^a   Chowdhury, Shahead Ali ^a   Chakrabarty, Sagarika ^a   Jin, Zhenzi ^a   Yasuda, Hisafumi ^a   Yokono, Koichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE 65; IMMUNOGLOBULIN; AUTOANTIBODY; AUTOANTIGEN; CASEIN; GLUTAMATE DECARBOXYLASE; ISOENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PREVALENCE; RADIOIMMUNOASSAY; ADOLESCENT; AGED; CELL DIVISION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PANCREAS ISLET; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CASEINS; CELL DIVISION; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; ISOENZYMES; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 17344392061     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.8.1390     Document Type: Article

References (29)

1. Roep BO, Kallan AA, De Vries RR: β-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient: a putative mechanism of T-cell-mediated autoimmune islet cell destruction. Diabetes 41:1380-1384, 1992
2. Foulis AK, McGill M, Farquharson MA: Insulins in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 165:97-103, 1991
3. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39:60-69, 1996
4. Campbell IL, Kay TWH, Oxbrow L, Harrison LC: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1993
5. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleakley RC, Power RF: IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune.diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1995
6. Rabinovitch A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151, 1998
7. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
8. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS, and Participating Laboratories: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
9. Leslie RDG, Atkinson MA, Notkins AL: Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 42:3-14, 1999
10. Libman IM, Pietropaolo M, Trucco M, Dorman JS, La Porte RE, Becker D: Islet cell autoimmunity in white and black children and adolescents with IDDM. Diabetes Care 21:1824-1827, 1998
11. Yamada H, Uchigata Y, Kawasaki E, Matsuura N, Otani T, Sato A, Mutoh K, Kasahara T, Fukushima N, Koike A, Mizota M, Miura J, Kubo H, Yamaguchi A, Nagataki S, Omori Y, Iwamoto Y: Onset age-dependent variations of three islet specific autoantibodies in Japanese IDDM patients. Diabetes Res Clin Pract 39:211-217, 1998
12. Ohta M, Ohta K, Obayashi H, Nakamura N, Shigeta H, Nakano K, Hasegawa G, Fukui M, Kitagawa Y, Nishimura M, Itoh N: Clinical evaluation of a radioimmuno-precipitation assay for IA-2 antibody and comparison of GAD antibody in type 1 diabetes mellitus. Autoimmunity 32:79-88, 2000
13. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y: Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191-199, 1995
14. Kobayashi T, Tamemoto K, Nakanishi H, Kato N, Okubo M, Kajio H, Sugimoto T, Murasa T, Kosaka K: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788, 1993
15. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Autoantibodies to glutamate acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
16. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA: Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. J Autoimmun 13:267-282, 1999
17. Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, Roep BO: Characterization of preparation of GAD65, proinsulin, and islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cell in type 1 diabetes: report of phase II of the second international immunology of diabetes society workshop for standardization of T-cell assays in type 1 diabetes. Diabetes 50:1749-1754, 2001
18. 123I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta 256:175-188, 1996
19. Masuda M, Powell M, Chen S, Beer C, Fichna P, Smith BR, Furmaniak J: Autoantibodies to IA-2 in insulin-dependent diabetes measurement with a new immunoprecipitation assay. Clin Chim Acta 291:53-66, 2000
20. Karlsson MGE, Lawesson SS, Ludvigsson J: Th1-like dominance in high-risk first-degree relatives of type 1 diabetic patients. Diabetologia 43:742-749, 2000
21. Alleva DG, Crowe PD, Jin L, Kwok WW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putnam AL, Gaur A: A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 107:173-180, 2001
22. Redondo MJ, Gottlieb PA, Motheral T, Mulgrew C, Rewers M, Babu S, Stephens E, Wegmann DR, Eisenbarth GS: Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes 48:2166-2170, 1999
23. Martin R, Jaraquemada D, Flerlage M Jr, Richert JR, Whitaker J, Long EO, McFarlin DE, McFarland HF: Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145:540-548, 1990
24. Ota K, Masui EL, Milford GA, Mackin GA, Weiner HL, Hafler DA: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187, 1990
25. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen T, Kappos L, Wekerle H: Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci U S A 87:7968-7972, 1990
26. Bieganowska KD, Ausubel LJ, Modabber Y, Slovik E, Messersmith W, Hafler DA: Direct ex vivo analysis of activated. Fassensitive autoreactive T cells in human autoimmune disease. J Exp Med 185:1585-1594, 1997
27. Reijonen H, Daniels TL, Lernmark A, Nepom GT: GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 49:1621-1626, 2000
28. Cavallo MG, Fava D, Monetini L, Barone F, Pozzilli P: Cell-mediated immune response to β-casein in recent-onset insulin-dependent diabetes: implications for diseases pathologenesis. Lancet 348:926-928, 1996
29. Ellis TM. Ottendorfer E, Jodoin E, Salisbury PJ, She JX, Schatz DA, Atkinson MA: Cellular immune responses to β-casein: elevated in but not specific for individuals with type 1 diabetes mellitus. Diabetologia 41:731-735, 1998